Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method

被引:93
|
作者
Smith, RH [1 ]
Jorgensen, WL
Tirado-Rives, J
Lamb, ML
Janssen, PAJ
Michejda, CJ
Smith, MBK
机构
[1] Western Maryland Coll, Dept Chem, Westminster, MD 21157 USA
[2] NCI, ABL, Basic Res Program, Frederick Res & Dev Ctr, Ft Detrick, MD 21702 USA
[3] Yale Univ, Dept Chem, New Haven, CT 06520 USA
[4] CMD, Janssen Res Fdn, B-2350 Vosselaar, Belgium
关键词
D O I
10.1021/jm9804174
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Monte Carlo (MC) simulations in combination with a linear response approach were used to estimate the free energies of binding for a series of 12 TIBO nonnucleoside inhibitors of HIV-1 reverse transcriptase. Separate correlations were made for the R-6 and S-6 absolute conformations of the inhibitors, as well as for the analogous N6-monoprotonated species. Models based upon the neutral unbound inhibitors produced overall better fits to experimental values than did those using the protonated unbound inhibitors, with only slight differences between the neutral R-6 and S-6 cases. The best results were obtained with a three-parameter linear response equation containing van der Waals (alpha), electrostatic (beta), and solvent accessible surface area (SASA, gamma) terms. The averaged (R-6 and S-6) rms error was approximately 0.88 kcal/mol for the observed range of 4.06 kcal/mol in inhibitor activities. The averaged values of alpha, beta, and gamma mere -0.150, 0.114, and 0.0286, respectively. Omission of the alpha term gave beta 0.152 and gamma 0.022 with a rms of 0.92. The unweighted van der Waals components were found to be highly attractive but failed to correlate well across the series of inhibitors. Contrastingly, while the electrostatic components are all repulsive, they show a direct correlation with inhibitor activity as measured by Delta G(binding). The role of gamma is primarily to produce an overall negative binding energy, and it can effectively be replaced with a negative constant. During the MC simulations of the unbound solvated inhibitors, the R-6 and S-6 absolute conformations do not interconvert; due to the formation of a favorable hydrogen bond to solvent. In the complex, however, interconversion of these conformations of the inhibitor is observed during the course of the simulations, a phenomenon which is apparently not observed in the crystalline state of the complex. Hydrogen bonding of the inhibitor to the backbone NH of K101 and the lack of such an interaction with the C=O of K101 or with solvent correlate with enhanced activity, as does the ability to assume a number of different orientations of the inhibitor dimethylallyl moiety with respect to residues Y181 and Y188 while retaining contact with W229. Overall, the use of a combination of MC simulation with a linear response method shows promise as a relatively rapid means of estimating inhibitor activities. This approach should be useful in the preliminary evaluation of potential modifications to known inhibitors to enhance activity.
引用
收藏
页码:5272 / 5286
页数:15
相关论文
共 50 条
  • [31] Oligonucleotide Inhibitors of HIV-1 Integrase Efficiently Inhibit HIV-1 Reverse Transcriptase
    Korolev, S. P.
    Zatsepin, T. S.
    Gottikh, M. B.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2017, 43 (02) : 135 - 139
  • [32] Oligonucleotide inhibitors of HIV-1 integrase efficiently inhibit HIV-1 reverse transcriptase
    S. P. Korolev
    T. S. Zatsepin
    M. B. Gottikh
    Russian Journal of Bioorganic Chemistry, 2017, 43 : 135 - 139
  • [33] Quantitative structure-activity relationships and comparative molecular field analysis of TIBO derivatised HIV-1 reverse transcriptase inhibitors
    Supa Hannongbua
    Pornpan Pungpo
    Jumras Limtrakul
    Peter Wolschann
    Journal of Computer-Aided Molecular Design, 1999, 13 : 563 - 577
  • [34] NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activities
    Thammaporn, Ratsupa
    Yagi-Utsumi, Maho
    Yamaguchi, Takumi
    Boonsri, Pornthip
    Saparpakorn, Patchreenart
    Choowongkomon, Kiattawee
    Techasakul, Supanna
    Kato, Koichi
    Hannongbua, Supa
    SCIENTIFIC REPORTS, 2015, 5
  • [35] NMR characterization of HIV-1 reverse transcriptase binding to various non-nucleoside reverse transcriptase inhibitors with different activities
    Ratsupa Thammaporn
    Maho Yagi-Utsumi
    Takumi Yamaguchi
    Pornthip Boonsri
    Patchreenart Saparpakorn
    Kiattawee Choowongkomon
    Supanna Techasakul
    Koichi Kato
    Supa Hannongbua
    Scientific Reports, 5
  • [36] Reverse transcriptase fidelity and HIV-1 variation - Response
    Prasad, VR
    Drosopoulos, WC
    Wainberg, MA
    SCIENCE, 1997, 275 (5297) : 230 - 231
  • [37] Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors
    Patel, M
    McHugh, RJ
    Cordova, BC
    Klabe, RM
    Erickson-Viitanen, S
    Trainor, GL
    Rodgers, JD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (15) : 1729 - 1731
  • [38] OLIGONUCLEOTIDE CONJUGATES AS INHIBITORS OF HIV-1 INTEGRASE AND REVERSE TRANSCRIPTASE
    Zatsepin, T.
    Agapkina, J.
    Korolev, S.
    Gottikh, M.
    NUCLEIC ACID THERAPEUTICS, 2011, 21 (05) : A31 - A31
  • [39] Peptides as new inhibitors of HIV-1 reverse transcriptase and integrase
    de Soultrait, VR
    Desjobert, C
    Tarrago-Litvak, L
    CURRENT MEDICINAL CHEMISTRY, 2003, 10 (18) : 1765 - 1778
  • [40] MOLECULAR MODELING OF HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS
    CRABBE, MJC
    FALKINGBRIDGE, SS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (03) : 261 - 264